par Sakuma, Masae;Arai, Hidekazu;Mizuno, Akira;Fukaya, Makiko
;Matsuura, Motoi;Sasaki, Hajime;Yamanaka-Okumura, Hisami;Yamamoto, Hironori;Taketani, Yutaka;Doi, Toshio;Takeda, Eiji
Référence Journal of clinical biochemistry and nutrition, 45, 2, page (155-162)
Publication Publié, 2009-09

Référence Journal of clinical biochemistry and nutrition, 45, 2, page (155-162)
Publication Publié, 2009-09
Article révisé par les pairs
Résumé : | A palatinose-based liquid formula (palatinose-formula), suppresses postprandial plasma glucose and insulin levels in healthy men. The objective of this study was to investigate the effects of long-term palatinose-formula ingestion on glucose metabolism in patients with impaired glucose tolerance (IGT) or type 2 diabetes. Two patients with IGT and 7 patients with type 2 diabetes participated in the palatinose-formula and dextrin-based liquid formula (dextrin-formula) loading test and long-term palatinose-formula administration study. After a 3-month control period, palatinose-formula (1046 kJ) was ingested daily by patients as a part of breakfast for 5 months. In the loading test, palatinose-formula suppressed postprandial plasma glucose and insulin levels and areas under the curve compared with those after dextrin-formula ingestion. In the long-term study, glycated hemoglobin levels (after 3 months and 5 months of treatment) and serum 8-hydroxydeoxyguanosine levels (after 5 months of treatment) were markedly decreased comparing with those at baseline. Intake of 1046 kJ palatinose-formula as a part of breakfast over a long-term period may be effective for improvement of glucose metabolism in patients with IGT or type 2 diabetes. |